Indication
Non-Hodgkin's lymphoma
Non-Hodgkin's lymphoma is a diverse group of hematologic malignancies originating from lymphoid tissues, primarily affecting B lymphocytes and less commonly T lymphocytes or natural killer (NK) cells. Read more about Non-Hodgkin's lymphoma
487 drugs 205 manufacturers
Drugs that treat it
Common Non-Hodgkin's lymphoma therapies.
MEDROL (PAK) (methylprednisolone)
MILLIPRED (prednisolone)
SOLU-MEDROL (PF) (methylprednisolone sodium succinate/PF)
SOLU-MEDROL (PF) (methylprednisolone sodium succinate/PF)
SOLU-MEDROL (PF) (methylprednisolone sodium succinate/PF)
SOLU-MEDROL (PF) (methylprednisolone sodium succinate/PF)
SOLU-CORTEF ACT-O-VIAL (PF) (hydrocortisone sodium succinate/PF)
DOUBLEDEX (PF) (dexamethasone sodium phosphate/PF)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonNon-Hodgkin's lymphoma is a diverse group of hematologic malignancies originating from lymphoid tissues, primarily affecting B lymphocytes and less commonly T lymphocytes or natural killer (NK) cells.
This disease directly involves the lymphatic and immune systems, frequently manifesting as painless lymphadenopathy in the neck, axillae, or groin, with potential dissemination to the spleen, bone marrow, and extranodal organs.
Pathophysiologically, it is driven by genetic mutations that cause the uncontrolled clonal proliferation, survival, and accumulation of abnormal lymphocytes without the presence of diagnostic Reed-Sternberg cells.
Clinically, it ranges from indolent to aggressive forms and often presents with systemic "B symptoms," including persistent fever, drenching night sweats, and unintentional weight loss.
- medlineplus.gov
Non-Hodgkin's lymphoma is a diverse group of hematologic malignancies originating from lymphoid tissues, primarily affecting B lymphocytes and less commonly T lymphocytes or natural killer (NK) cells This disease directly involves the lymphatic and immune systems, frequently manifesting as painless lymphadenopathy in the neck, axillae, or groin, with potential dissemination to the spleen, bone marrow, and extranodal organs Clinically, it ranges from indolent to aggressive forms and often present...
- nih.gov
Non-Hodgkin's lymphoma is a diverse group of hematologic malignancies originating from lymphoid tissues, primarily affecting B lymphocytes and less commonly T lymphocytes or natural killer (NK) cells Pathophysiologically, it is driven by genetic mutations that cause the uncontrolled clonal proliferation, survival, and accumulation of abnormal lymphocytes without the presence of diagnostic Reed-Sternberg cells Clinically, it ranges from indolent to aggressive forms and often presents with systemi...
- medlineplus.gov
This disease directly involves the lymphatic and immune systems, frequently manifesting as painless lymphadenopathy in the neck, axillae, or groin, with potential dissemination to the spleen, bone marrow, and extranodal organs
- columbiadoctors.org
This disease directly involves the lymphatic and immune systems, frequently manifesting as painless lymphadenopathy in the neck, axillae, or groin, with potential dissemination to the spleen, bone marrow, and extranodal organs
- healthline.com
Pathophysiologically, it is driven by genetic mutations that cause the uncontrolled clonal proliferation, survival, and accumulation of abnormal lymphocytes without the presence of diagnostic Reed-Sternberg cells Clinically, it ranges from indolent to aggressive forms and often presents with systemic "B symptoms," including persistent fever, drenching night sweats, and unintentional weight loss
- clevelandclinic.org
Pathophysiologically, it is driven by genetic mutations that cause the uncontrolled clonal proliferation, survival, and accumulation of abnormal lymphocytes without the presence of diagnostic Reed-Sternberg cells
Personalize your experience
Follow Non-Hodgkin's lymphoma and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.